Arcellx, Inc. (NASDAQ:ACLX) Receives $105.93 Average Price …

Jan 8, 2025 · Shares of Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) have received a consensus recommendation of “Buy” from the fifteen analysts that are currently covering the …

$105.93
OFF

Arcellx, Inc. (NASDAQ:ACLX) Receives $105.93 Average Price …

2 weeks from now

Jan 8, 2025 · Shares of Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) have received a consensus recommendation of “Buy” from the fifteen analysts that are currently covering the …

etfdailynews.com

$105.93
OFF

Arcellx, Inc. (NASDAQ:ACLX) Receives $105.93 Consensus PT From ...

2 weeks from now

Dec 14, 2024 · Read Arcellx, Inc. (NASDAQ:ACLX) Receives $105.93 Consensus PT from Brokerages at ETF Daily News. Shares of Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) …

etfdailynews.com

$105.93
OFF

Arcellx, Inc. (NASDAQ:ACLX) Receives $105.93 Consensus

2 weeks from now

Jan 5, 2025 · Arcellx (NASDAQ:ACLX - Get Free Report) last posted its quarterly earnings data on Thursday, November 7th.The company reported ($0.48) EPS for the quarter, beating the …

marketbeat.com

$105.93
OFF

Arcellx, Inc. (NASDAQ:ACLX) Receives $105.93 Consensus Target …

2 weeks from now

Dec 16, 2024 · Shares of Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) have received an average rating of “Buy” from the fifteen brokerages that are currently covering the firm, …

americanbankingnews.com

$88.50
OFF

Arcellx, Inc. (NASDAQ:ACLX) Receives $88.50 Average Price

2 weeks from now

Oct 22, 2024 · Arcellx, Inc. (NASDAQ:ACLX - Get Free Report) has received a consensus recommendation of "Buy" from the fourteen brokerages that are currently covering the …

marketbeat.com

$107.71
OFF

14 Analysts Have This To Say About Arcellx - Nasdaq

2 weeks from now

Dec 9, 2024 · Analysts have recently evaluated Arcellx and provided 12-month price targets. The average target is $107.71, accompanied by a high estimate of $136.00 and a low estimate of …

nasdaq.com

$0.48
OFF

Arcellx (ACLX) Stock Price, News & Analysis - MarketBeat

2 weeks from now

Jan 8, 2025 · Arcellx, Inc. (NASDAQ:ACLX) issued its quarterly earnings results on Thursday, November, 7th. The company reported ($0.48) EPS for the quarter, topping the consensus …

marketbeat.com

$115
OFF

Arcellx Price Target Raised To $115 From $73 At Barclays

2 weeks from now

Nov 30, 2024 · Barclays raised the firm’s price target on Arcellx (ACLX) to $115 from $73 and keeps an Overweight rating on the shares following a transfer of coverage. The firm sees an …

nasdaq.com

56%
OFF

Arcellx (NASDAQ:ACLX) Sees Unusually-High Trading Volume

2 weeks from now

Jan 6, 2025 · Arcellx, Inc. (NASDAQ:ACLX - Get Free Report) shares saw an uptick in trading volume on Monday . 636,156 shares were traded during trading, an increase of 56% from the …

marketbeat.com

$47.88
OFF

Arcellx, Inc. (NASDAQ:ACLX) Shares Sold By JPMorgan Chase & Co.

2 weeks from now

6 days ago · Arcellx, Inc. has a 1-year low of $47.88 and a 1-year high of $107.37. The company has a 50 day moving average of $85.45 and a 200-day moving average of $75.61. Arcellx …

marketbeat.com

FAQs about Arcellx, Inc. (NASDAQ:ACLX) Receives $105.93 Average Price … Coupon?

Should you buy arcellx (aclx) stock?

Shares of Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) have received a consensus recommendation of “Buy” from the fifteen analysts that are currently covering the stock, MarketBeat reports. Thirteen equities research analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. ...

How many research reports have been made about arcellx?

Arcellx has only been the subject of 4 research reports in the past 90 days. Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. ...

How do I receive news & ratings for arcellx?

Receive News & Ratings for Arcellx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcellx and related companies with MarketBeat.com's FREE daily email newsletter. He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. ...

Does Decheng Capital LLC own arcellx?

Decheng Capital LLC acquired a new position in Arcellx during the second quarter valued at $65,000. National Bank of Canada FI boosted its holdings in Arcellx by 50.0% in the second quarter. National Bank of Canada FI now owns 1,500 shares of the company’s stock valued at $80,000 after purchasing an additional 500 shares during the last quarter. ...

What is arcellx's lead ddcar product candidate?

Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). ...

Where can I buy aclx stock?

Shares of ACLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. ...